WebFeb 28, 2024 · The use of induced Pluripotent Stem Cells (iPSC) as a source of autologous tissues shows great promise in regenerative medicine. Nevertheless, several major challenges remain to be addressed before iPSC-derived cells can be used in therapy, and experience of their clinical use is extremely limited. … WebMar 13, 2011 · Models using iPS cells have proliferated in a few short years: they are now available for, among other things, motor neurone disease, juvenile diabetes and sickle cell anaemia.
Stem cell-derived exosome versus stem cell therapy
WebInvestigation of embryonic and adult (tissue) stem cells as potential cell sources for tooth regeneration has led to many promising results. However, technical and ethical issues have hindered the availability of these cells for clinical application. The recent discovery of induced pluripotent stem (iPS) cells has provided the possibility to ... WebJun 10, 2009 · Although iPSCs may appear to solve the controversy over the destruction of embryos in embryonic stem cell (ESC) research by involving only the genetic reprogramming of somatic cells, further analysis of the new technique and its … pylusd
Ethical and Safety Issues of Stem Cell-Based Therapy - PubMed
WebMay 1, 2009 · The reprogramming of somatic cells to produce induced pluripotent stem cells (iPS cells) avoids the ethical problems specific to embryonic stem cells. With any … WebSep 6, 2024 · The use of induced pluripotent stem cells (iPSCs) represents a great promise in regenerative medicine. So far, several clinical trials are underway and preliminary results are promising with the human embryonic stem cells, their non-reprogrammed counterparts. The experience of the clinical use of iPSC derivatives is extremely limited … WebMay 14, 2024 · Stem cells in personalized medicine. A key advantage of iPS cells is that they can be used to make models specific to individual patients. Using banks of stem cells from a wide variety of genetic backgrounds would enable personalizing the treatment to the individual genetic and cellular makeup of each patient. pylumid